Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
38.98
+1.59 (4.25%)
Jun 3, 2025, 3:04 PM CST
SHE:300255 Revenue
Hebei Changshan Biochemical Pharmaceutical had revenue of 258.70M CNY in the quarter ending March 31, 2025, a decrease of -12.10%. This brings the company's revenue in the last twelve months to 995.20M, down -17.26% year-over-year. In the year 2024, Hebei Changshan Biochemical Pharmaceutical had annual revenue of 1.03B, down -26.92%.
Revenue (ttm)
995.20M
Revenue Growth
-17.26%
P/S Ratio
36.00
Revenue / Employee
793.62K
Employees
1,254
Market Cap
35.82B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.03B | -379.63M | -26.92% |
Dec 31, 2023 | 1.41B | -925.79M | -39.63% |
Jan 1, 2023 | 2.34B | -631.82M | -21.29% |
Jan 1, 2022 | 2.97B | 604.26M | 25.56% |
Dec 31, 2020 | 2.36B | 292.31M | 14.11% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |